CLINICAL_TRIALS
trial_result
· 2015-08-19
Clinical Trial Update: Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer [Phase 1]
Summary
A Phase 1 study evaluating nimotuzumab in combination with chemoradiation for advanced esophageal cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biotech Pharmaceutical Co., Ltd. | Conditions: Advanced Esophageal | Phase 1 | Status: COMPLETED